Dramatic Inhibition of Retinal and Choroidal Neovascularization by Oral Administration of a Kinase Inhibitor
Open Access
- 30 June 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (6), 1743-1753
- https://doi.org/10.1016/s0002-9440(10)65430-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine ModelThe American Journal of Pathology, 1998
- Essential Role of Growth Hormone in Ischemia-Induced Retinal NeovascularizationScience, 1997
- Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman PrimateArchives of Ophthalmology (1950), 1996
- Different Susceptibility of Protein Kinases to Staurosporine InhibitionEuropean Journal of Biochemistry, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Detection of Vascular Endothelial Growth Factor Messenger RNA and Vascular Endothelial Growth Factor-like Activity in Proliferative Diabetic RetinopathyArchives of Ophthalmology (1950), 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activityInternational Journal of Cancer, 1989
- The molecular heterogeneity of protein kinase C and its implications for cellular regulationNature, 1988
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986